Insulin-like growth factor I is a possible pathogenic mechanism in nasal polyps
- 1 January 1988
- journal article
- research article
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 106 (1-2) , 156-160
- https://doi.org/10.3109/00016488809107384
Abstract
High concentrations of the trophic peptide insulin-like growth factor I (IGF-I; somatomedin C; SmC) were demonstrated immunocytochemically in all nasal polyps examined, except in areas with necrosis or tissue defects. Most epithelial cells, activated macrophages, and proliferating blood vessels, proved positive, contrasting with the low degree of cellular staining in adjacent normal nasal mucosa. It is proposed that nasal mucosal inflammatory reactions induce local formation and accumulation of IGF-I, which may eventually result in very high IGF-I concentrations in the paranasal sinuses due to the tendency these have to be enclosed, i.e. producing reduced drainage. Assuming that IGF-I constitutes the pathogenic factor, appropriate treatment should be given to reduce the inflammatory reactions and improve drainageKeywords
This publication has 8 references indexed in Scilit:
- Regenerating skeletal muscle cells express insulin‐like growth factor IActa Physiologica Scandinavica, 1987
- Evidence indicating trophic importance of IGF‐1 in regenerating peripheral nervesActa Physiologica Scandinavica, 1986
- SOMATOMEDIN C IN PATHOGENESIS OF MALIGNANT EXOPHTHALMOS OF ENDOCRINE ORIGINThe Lancet, 1986
- Structural and Functional Aspects of Cells in the Nasal Mucociliary SystemJAMA Otolaryngology–Head & Neck Surgery, 1984
- Localization of ribonucleotide reductase in mammalian cells.The EMBO Journal, 1984
- Glucocorticoid Therapy in ChildrenAmerican Journal of Diseases of Children, 1975
- NECROSING ETHMOIDITIS ; ITS RELATIONSHIP TO THE DEVELOPMENT OF NASAL POLYPUS, OZÆNA, &c.The Lancet, 1885